Arizona Tribune - Boulevard

NYSE - LSE

CMSC	-0.09%	21.29	$
JRI	-0.4%	12.35	$
VOD	1%	16.04	$
BCC	-0.03%	78.75	$
BCE	0.26%	23.46	$
BP	-0.45%	42.15	$
RBGPF	0.11%	70.77	$
BTI	-0.27%	56.13	$
GSK	1.08%	50.82	$
RELX	0.66%	36.54	$
NGG	-0.1%	79.35	$
CMSD	0%	21.18	$
AZN	-1.12%	162.7	$
RIO	-1.43%	103.3	$
RYCEF	-1.22%	20.5	$

Featured

UN, Nepal warn of climate threat after deadly floods

Nepal's foreign minister and the UN climate chief on Saturday warned of the growing threat from global warming to the Himalayas, as rescuers race to find thousands missing after torrential flooding along the border with China.

Rescuers dig into tunnel as missing toll from Nepal, China flood nears 3,000

Rescuers in Nepal and China on Saturday battled to locate thousands of people missing days after a deadly, tsunami-like wall of water and debris swept through the Himalayan region, engulfing entire villages.

Last news

The NITE FLAG XL Launches October 28, 2025 - The Flag of the 21st Century

THE FUTURE OF FLAGS IS NOW- THE NITE FLAG COMPANY"Always Waves. Never Sags. Lights Up the Night."

Modular Medical Announces Ongoing Progress to Obtain CE Mark

Key Highlights:Pivot continues to progress toward CE Mark certification in 2026Stage 1 ISO Audit completed with Stage 2 planned for 1H2026

VSee Awarded US Department of Health & Human Services FedRAMP High ATO

SAN JOSE, CALIFORNIA / ACCESS Newswire / October 28, 2025 / VSee Health, Inc. (Nasdaq:VSEE) (the "Company"), announced it has received its Authority to Operate (ATO) at the FedRAMP High level from the U.S. Department of Health and Human Services (HHS). The authorization also allows other federal agencies to use VSee where FedRAMP High is required.

Florence Healthcare Launches SiteLink on AWS Marketplace, Extending its Clinical Trial Operations Platform Capabilities to Cloud

ATLANTA, GEORGIA / ACCESS Newswire / October 28, 2025 / Florence Healthcare, the leading clinical trial platform connecting pharmaceutical sponsors and research sites worldwide, announced today that SiteLink, a key offering of Florence's Trial Operations Platform, is now available in AWS Marketplace.

Sunshine Biopharma Gains FDA-Equivalent Clearance in Canada for Domperidone to Treat Cancer-related Nausea

FORT LAUDERDALE, FL / ACCESS Newswire / October 28, 2025 / Sunshine Biopharma Inc. (NASDAQ:SBFM) (the "Company"), a leading pharmaceutical company focused on innovative and affordable healthcare solutions, today announced that its wholly owned subsidiary, Nora Pharma Inc., has received approval from Health Canada, the Canadian equivalent to the FDA, for the commercialization of Domperidone, a prescription medication used to relieve nausea and vomiting and to enhance gastrointestinal motility.

Date Change for Bike MS: Historic New Bern Ride 2026!

Cycling for a Cure to End Multiple Sclerosis

CBD Life Sciences Inc. (OTC: CBDL) Launches Tremendous Energy & Weight-Loss Diet Hemp-Free Gummies

Global functional gummy supplements market projected to surpass $50 billion by 2030 - CBDL expands into two of the fastest-growing segments in wellness and performance nutrition.

Venezuela claims CIA 'false flag' attack foiled, as US deploys bombers

Venezuela claimed Monday to have dismantled a CIA-financed cell plotting a false-flag attack on a US warship deployed to the southern Caribbean, as Washington stepped up pressure on Caracas by flying bombers nearby.

Brazil ex-leader Bolsonaro appeals 27-year prison sentence

Former Brazilian president Jair Bolsonaro's lawyers on Monday filed an appeal against his 27-year prison sentence for a botched coup bid after his 2022 election loss.

'Not our first hurricane': Jamaicans prepare to ride out deadly Melissa

Melissa could be the worst hurricane Jamaica has experienced since recordkeeping began -- but some residents on the Caribbean island say they will believe it when they see it.

AI-generated fakes proliferate as Hurricane Melissa nears Jamaica

AI-generated videos were clogging social media feeds Monday as Hurricane Melissa surged toward Jamaica, diverting attention from critical safety information about the massive Category 5 storm.

NBA reviewing policies to fight 'dire risks' of gambling: report

The NBA is reviewing league policies to ensure players know gambling's "dire risks" according to a league memo reportedly sent to teams Monday in the wake of a betting scandal.

American jazz drummer Jack DeJohnette dies

US jazz drummer Jack DeJohnette, a major figure in modern jazz who collaborated with Miles Davis and Keith Jarrett, has died at 83, his management said on Monday.

'A kind of freedom': Amsterdam celebrates 750 years

World-famous city of canals, bikes and tolerance, Amsterdam celebrated 750 years since its founding Monday, but the Dutch capital is now grappling with the very modern problems of overtourism and a housing shortage.

UK activists who tried to paint Taylor Swift jet spared jail

Two climate activists were Monday spared jail by a UK court after they sprayed two planes with orange paint to protest US pop star Taylor Swift's use of private jets.

Category 5 Hurricane Melissa strengthens as it heads for Jamaica

Hurricane Melissa strengthened Monday as it took aim at Jamaica and other parts of the Caribbean as a top-level Category 5 storm, with forecasters predicting catastrophic flooding and urging residents to seek shelter immediately.

Australian Murray cod wallops swim record

An Australian freshwater Murray cod has surprised scientists by swimming a marathon 860 kilometres (530 miles) along a major river system -- believed to be a record for the species.

Murder, kidnap, censorship: the 'new normal' of Tanzania politics

A priest attacked after a meeting about democracy with faith leaders, an opposition official's corpse found doused in acid, an ex-ambassador missing from his blood-stained home -- this is the "new normal" in Tanzania, say critics.

Venezuela says US military exercises on nearby island a 'provocation'

Venezuela on Sunday blasted the arrival in nearby Trinidad and Tobago of a US warship as a dangerous "provocation," amid mounting fears of potential attacks against the Venezuelan mainland.

Menhaden Fisheries Coalition Refutes False Claims by Chesapeake Bay Foundation's Chris Moore

WASHINGTON, DC / ACCESS Newswire / October 27, 2025 / At a Chesapeake Bay Foundation (CBF) event titled "The Impacts of Climate on Fisheries," held on September 24, 2025, at the Virginia Aquarium & Marine Science Center in Virginia Beach, Chris Moore, CBF's Senior Regional Ecosystem Scientist, made several inaccurate statements about the Atlantic menhaden fishery and its management.

Forte Group Announces Amended Terms to Previously Announced Warrant Amendment

VANCOUVER, BRITISH COLUMBIA / ACCESS Newswire / October 27, 2025 / Forte Group Holdings Inc. (CSE:FGH)(OTC:FGHFF)(FSE:7BC0, WKN:A40L1Z) ("Forte Group" or the "Company"), a next-generation beverage and nutraceutical company focused on longevity and human performance, announces that further to its news release dated October 10, 2025 (the "Initial Disclosure"), which outlined its intention to amend the price and term of an aggregate of 1,152,937 common share purchase warrants (the "Repriced Warrants") aimed at strengthening its financial position, the Company advises that it will amend the exercise price of the Repriced Warrants to $0.30 per share, effective October 24, 2025, in accordance with Policy 6.7(6)(b) of the Canadian Securities Exchange ("CSE").

Statement of the Menhaden Fisheries Coalition on the Upcoming Atlantic Menhaden Management Board Meeting

WASHINGTON, DC / ACCESS Newswire / October 27, 2025 / Tomorrow, the Atlantic States Marine Fisheries Commission's Menhaden Board is slated to take up several issues which have the potential to gravely impact this historic fishery. First, it will consider the results of the menhaden and ecological reference points ("ERP") stock assessment. Despite a lower estimate of menhaden fecundity, the stock status remains not overfished and overfishing is not occurring. The assessment team attributed this to the fact that menhaden "management has consistently been more conservative than single-species reference points would have historically prescribed."

Newsmax Signs Deal to Make Channel Available in 900+ Hotels, 300,000 Rooms Nationwide

BOCA RATON, FL / ACCESS Newswire / October 27, 2025 / Newsmax Inc. (NYSE:NMAX) ("Newsmax" or the "Company") today announced a new agreement with the leading provider of in-room entertainment for the hospitality industry that delivers the Newsmax channel to more than 900 hotels and 300,0000 hotel rooms across the U.S.

Menhaden Misinformation: Four Organizations Push Drastic Cuts that Contradict the Assessment Record and Ecosystem-Based Management

WASHINGTON, DC / ACCESS Newswire / October 27, 2025 / The Chesapeake Bay Foundation (CBF), American Sportfishing Association (ASA), Theodore Roosevelt Conservation Partnership (TRCP), and the American Saltwater Guides Association (ASGA) are circulating claims about Atlantic menhaden that don't match the assessment record or how this fishery is managed.

New to The Street's Esteemed Partner, HPB, Says China's Export Controls Shows Where Europe's Battery Security Depends

NEW YORK CITY, NY / ACCESS Newswire / October 27, 2025 / China's tightening of export rules for lithium batteries, cathode materials and graphite has revealed a structural weakness in Europe's energy transition. German solid-state battery technology developer HPB says that the solution will not come from new trade routes but from new materials. The answer lies not in stockpiling materials but in rethinking how batteries are designed and built.

SoftWriters Welcomes Jeff Hlozek as Chief Revenue Officer

Executive leadership expansion in long-term care pharmacy technology reflects the growing demand driven by America's aging population and rising senior care needs.

Medical Care Technologies Inc. (OTC PINK:MDCE) Approved as an Official Google Play Developer

Company advances digital technology initiatives with approval to publish applications on the Google Play Store.

NanoViricides to Present at the PODD 2025 Conference in Boston on October 27

SHELTON, CT / ACCESS Newswire / October 27, 2025 / NanoViricides, Inc. (NYSE American: NNVC ) (the "Company"), a clinical stage leader developing revolutionary broad-spectrum antiviral drugs that the virus cannot escape, announced that it will be presenting on Monday, October 27th, at 03:00pm at the PODD 2025 Conference in Boston, MA.

Stemtech Corporation - Stemtech Healthsciences India Pvt Ltd Announces Strategy for Market Entry

NAPLES, FL / ACCESS Newswire / October 27, 2025 / "STEMTECH CORPORATION", the global leader and pioneer in stem cell nutrition and Innoventure Dynamic LLC of India announced on October 23, 2025, a dynamic joint venture, creating Stemtech HealthSciences India Pvt Ltd, a subsidiary of Stemtech Corporation, a Nevada company (OTCQB:STEK).

Protagonist Announces New Icotrokinra Data in Ulcerative Colitis and Plaque Psoriasis Presented at Two Recent Medical Conferences

Icotrokinra demonstrated clinically meaningful outcomes at Week 28 in the Phase 2b ANTHEM-UC study in ulcerative colitis, with 31.7% of patients achieving clinical remission and 38.1% showing endoscopic improvement versus placeboUpdated ANTHEM-UC data support Phase 3 clinical development of icotrokinra in both moderately to severely active ulcerative colitis and Crohn's diseaseIn areas of high impact, 72% of patients with scalp psoriasis and 85% with genital psoriasis treated with icotrokinra achieved site-specific clear or almost clear skin at Week 52 in Phase 3 ICONIC-TOTAL studyFurther, 67% of patients treated with icotrokinra in the ICONIC-TOTAL study achieved overall rates of clear or almost clear skin by Week 24, which was maintained through Week 52

Amphastar Pharmaceuticals to Release Third Quarter Earnings and Hold Conference Call on November 6th, 2025

RANCHO CUCAMONGA, CA / ACCESS Newswire / October 27, 2025 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced that the Company will release results for its third quarter of 2025 ended September 30, 2025, after the market closes on Thursday, November 6, 2025, and will hold a conference call to discuss its financial results at 2:00 p.m. Pacific Time.

Evotec Announces Progress in Preclinical Neuroscience Partnership with Bristol Myers Squibb

Advances made in preclinical pipeline addressing neurodegenerative diseasesEvotec receives US$ 25 m payment to support continued progression of joint programs

Arizona Tribune - Boulevard (English)